arrow
J

Jordi Clarimón

neurology department and institut de recerca sant pau
H指数:77
被引数:3.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer’s disease

疾病突变的结构域定位揭示了阿尔茨海默氏病的致病性SORL1变体

2025-12-010
OAAI
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

全基因组分析揭示了MAPT,MOBP和APOE基因座在散发性额颞叶痴呆中的潜在作用

2024-07-010
OAAI
Genome sequence analyses identify novel risk loci for multiple system atrophy

基因组序列分析确定多系统萎缩的新风险位点

NEURON
IF15
2024-07-013
OAAI
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors

超过7,000人的生物流体中颗粒蛋白前体浓度的系统评价-评估GRN突变的致病性和其他影响因素

2024-03-286
OAAI
Association of cardiovascular disease management drugs with Lewy body dementia: a case-control study

心血管疾病管理药物与路易体痴呆的关系: 一项病例对照研究

2023-12-183
OA
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

阿尔茨海默氏症和帕金森氏病中HLA基因座的多血统分析揭示了由HLA-DRB1 * 04亚型介导的共享适应性免疫反应

2023-08-299
OAAI
Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia (vol 10, 50, 2021)
2023-05-090
OAAI
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome

唐氏综合症成人的生物学性别与阿尔茨海默病的临床结局和生物标志物的关联

2023-03-1717
OAAI
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

拥抱单基因帕金森病: MJFF全球遗传PD队列

2023-01-2424
OAAI
Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer's disease

外显子组测序鉴定ATP8B4和ABCA1中罕见的破坏性变异为阿尔茨海默病的危险因素

2022-11-2180
OAAI
Intermediate and Expanded HTT Alleles and the Risk for α-Synucleinopathies

中间和扩展的HTT等位基因以及 α-突触核蛋白病的风险

2022-07-198
PRE
New insights into the genetic etiology of Alzheimer's disease and related dementias

对阿尔茨海默氏病和相关痴呆症的遗传病因的新见解

2022-04-04919
OAAI
Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia

血浆胶质纤维酸性蛋白和神经丝轻链用于额颞叶痴呆的诊断和预后评估

2021-12-1051
OAAI
Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat

低剂量verubecestat治疗的阿尔茨海默病患者的神经病理学

2021-12-071
PREAI
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome
2021-07-1435
OAAI
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome

VAMP-2是唐氏综合症成人阿尔茨海默氏症相关认知障碍的替代脑脊液标志物

2021-06-286
OAAI
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias

使用血浆生物标志物进行神经退行性痴呆的AT(N) 分类

2021-06-0839
OA
Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

APOE,GRN和TP53的遗传变异是额颞叶痴呆的表型修饰因子

2021-03-017
OAAI
Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve

额颞叶痴呆行为变异的性别差异: 执行和行为储备的新窗口

2021-02-1642
OAAI
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

基因组测序分析确定了与路易体痴呆相关的新基因座,并提供了对其遗传结构的见解

2021-02-15201
OAAI